Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor

Human Molecular Genetics

Volumn 9, Issue 13, 2000, Pages 1943-1949

  Glenn, C L ^a   Wang, W Y S ^a   Benjafield, A V ^a   Morris, B J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMA PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; AUSTRALIA; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HAPLOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; METABOLIC DISORDER; PARENT; PRIORITY JOURNAL; PROGENY; SYSTOLIC BLOOD PRESSURE;

EID: 0034641601     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.13.1943     Document Type: Article

References (54)

1. Tumor necrosis factor in the heart
2. Mechanisms of TNF-α-induced insulin resistance
3. The role of TNF-α in human adipose tissue: Prevention of weight gain at the expense of insulin resistance?
4. Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor
5. Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1
6. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: Selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1β, tumor necrosis basic fibroblast growth factor
7. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptor
8. Tumor necrosis factor's cytotoxic activity is signalled by the p55 TNF receptor
9. The two different receptors for tumor necrosis factor mediate distinct cellular responses
10. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
11. The immune system and hypertension
12. Do immune system changes have a role in hypertension?
13. Preactivated peripheral blood monocytes in patients with essential hypertension
14. Monocyte adhesion to cerebromicrovascular endothelial cells derived from hypertensive and normotensive rats
15. Chlamydia pneumoniae antibodies in severe essential hypertension
16. Association of Helicobacter pylori infection with coronary heart disease
17. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle
18. Cytokines affect ion transport in primary cultured thick ascending limb of Henle's loop cells
19. Tumor necrosis factor-α-angiotensin interactions and regulation of blood pressure
20. Hypertension as a disease of carbohydrate and lipoprotein metabolism
21. Tumor necrosis factor α: A key component of the obesity-diabetes link
22. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy
23. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion
24. Anti-tumour necrosis factor-α treatment interferes with changes in lipid metabolism in a tumour cachexia model
25. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance
26. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance
27. Physical mapping and genome structure of the human TNFR2 gene
28. Estimation of linkage disequilibrium in randomly mating populations
29. Comparison of nonparametric statistics for detection of linkage in nuclear families: Single-marker evaluation
30. Affected-sib-pair interval mapping and exclusion for complex genetic traits: Sampling considerations
31. Genetic analysis of inherited hypertension in the rat
32. Genetic dissection of complex traits
33. Empirical genomewide significance levels established by whole genome simulations
34. Linkage disequilibrium as a gene-mapping tool
35. Prospects for whole-genome linkage disequilibrium mapping of common disease genes
36. Genetic epidemiology of single-nucleotide polymorphisms
37. Molecular genetic analyses of RFLPs for PCR-amplified growth hormone gene, renal kallikrein gene and atrial natriuretic factor gene in essential hypertension
38. Polymorphism (1339G>A;A447T) in exon 13 of human kidney chloride channel gene CLCNKA
39. Use of the robust sib-pair method to screen for single-locus, multiple-locus, and pleiotropic effects: Applications to traits related to hypertension
40. Tests and estimates of allelic association in complex inheritance
41. The information contained in multiple sibling pairs
42. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
43. Polygenic disease: Methods for mapping complex disease traits
44. Exclusion of angiotensinogen gene in molecular basis of human hypertension: Sibpair linkage and association analyses in Australian Anglo-Caucasians
45. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals
46. Glucagon receptor gene mutation in essential hypertension
47. G-protein β3 subunit gene (GNB3) variant in causation of essential hypertension
48. Polymerase chain reaction-single strand conformation polymorphism or how to detect reliably and efficiently each sequence variation in many samples and many genes
49. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization
50. Efficiency of typing unaffected relatives in an affected-sib-pair linkage study with single-locus and multiple tightly-linked markers
51. The affected sib-pair method using identity by state relations
52. Linkage strategies for genetically complex traits. II. The power of affected relative pairs
53. Complete multipoint sib-pair analysis of qualitative and quantitative traits